Business Wire

Regnology Announces the 31st Annual RegTech Convention on November 18-21

24.9.2024 09:30:00 EEST | Business Wire | Press release

Share

Regnology, a leading software provider with a focus on regulatory reporting solutions, is excited to announce the 31st Annual RegTech Convention, set to take place from November 18-20, 2024 in Frankfurt, Germany and in Zürich, Switzerland on November 21. This premier event will bring together over 2,000 attendees from 120 countries, featuring prominent industry speakers across 60+ sessions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240923712167/en/

Held under the motto “TechReg – the power to transform”, the convention will question how the rapidly shifting tech paradigm has the potential to profoundly redefine the foundations of regulatory reporting, shifting from a reactive to a proactive approach driven by efficiency and enhanced transparency, and built on informed decision-making.

Attendees will delve into the latest regulatory reforms, including IReF, ESG, and Basel IV, and discuss how innovations such as GenAI and hyperscale cloud technologies are reshaping the future of regulatory reporting. The conference will also explore how, on both sides of the regulatory spectrum, financial authorities and supervised financial entities can navigate uncharted waters to future-proof reporting processes.

This year’s convention will feature keynote addresses from Fredrik Reinfeldt, former Swedish Prime Minister (2006-2014) and member of the European Commission on macroeconomic dynamics and regulatory impact, and Dr. Ranja Reda Kouba, Head of Customer Engineering, Financial Services Germany at Google Cloud, who will share her visionary outlook on technological innovation within the financial industry.

The hybrid conference will host over 60 sessions and feature an impressive lineup of prominent speakers from major financial institutions, regulatory bodies, and technology firms worldwide, including the European Central Bank (ECB), Conference of State Bank Supervisors (CSBS), BIS Innovation Hub, Central Bank of the Philippines, Bank of Finland, Banca d’Italia, Banque du Liban, Cambridge SupTech Lab, Caixabank, Commerzbank, Rabobank, and OLB Bank.

In addition to the main conference days, attendees can participate in our local community events in UK, France and Switzerland designed to extend and enhance the experience with diverse topics and enriched content.

Rob Mackay, CEO of Regnology, commented: “With the rapid advancements in AI and hyperscale cloud technologies, the regulatory environment is constantly shifting. This year’s RegTech Convention is especially relevant for industry professionals looking to stay ahead in regulatory reporting.”

This event is free for regulatory authorities and financial institutions, with both in-person and online participation options available. The full convention will be live-streamed and available on-demand following the event.

To view the full agenda and register for the event please visit https://www.regtech-convention.com/en/register/.

About Regnology

Regnology is a leading technology firm on a mission to bring safety and stability to the financial markets. With an exclusive focus on regulatory reporting and more than 35,000 financial institutions, 70 regulators, international organizations, and tax authorities relying on our solutions to process their regulatory reporting data, we’re uniquely positioned to bring greater data quality, efficiency, and cost savings to all market participants. With over 900 employees in 16 countries and a unified data ingestion model powering our work, our clients can quickly implement and derive value from our solutions and easily keep pace with ongoing regulatory changes. Regnology was formed in 2021 when BearingPoint RegTech, a former business unit of BearingPoint Group, joined forces with Vizor Software, a global leader in regulatory and supervisory technology. The company is on a continued organic and external growth path, building up as one of the world's most recognized regulatory reporting powerhouses.

For more information about Regnology, connect with us on LinkedIn and X.

Visit our website: www.regnology.net.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240923712167/en/

Contacts

Mireille Adebiyi, Chief Marketing Officer
mireille.adebiyi@regnology.net

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 18:51:00 EEST | Press release

Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 17:25:00 EEST | Press release

Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensuring your investment is delivering.” The rapid growth of the residential solar market created a growing population of “orphaned” solar sy

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release

A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release

Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release

Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye